CVS Health insider trading
CVSfinancial statementsForm 4 filings on EDGAR110 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at CVS Health bought $0 of stock in the open market, and 0 sold $0. Officers and directors accounted for $0 of purchases and $0 of sales. The last reported transaction was a tax withholding by Clark James David on June 26, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through June 29, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $0Aug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
110 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Clark James David | SVP, Cont & Chief Acct Officer | tax withholding | 454 | $90.98 | $41K | 27,606 | Jun 29, 2026 |
| May 31, 2026 | Newman Brian | EVP, Chief Financial Officer | tax withholding | 2,478 | $90.98 | $225K | 3,008 | Jun 1, 2026 |
| May 31, 2026 | Compton-Phillips Amy | EVP, Chief Medical Officer | tax withholding | 7,618 | $90.98 | $693K | 9,557 | Jun 1, 2026 |
| May 21, 2026 | Aguirre Fernando | Director | disposition to issuer | 1,563 | $93.50 | $146K | 10,513 | May 22, 2026 |
| May 21, 2026 | Robbins Larry | Director | open-market saleindirect | 370,462 | $93.45 | $35M | 5M | May 21, 2026 |
| May 20, 2026 | Aguirre Fernando | Director | disposition to issuer | 30,437 | $93.78 | $3M | 12,076 | May 22, 2026 |
| May 20, 2026 | Robbins Larry | Director | open-market saleindirect | 797,628 | $93.48 | $75M | 5M | May 21, 2026 |
| May 20, 2026 | Robbins Larry | Director | open-market saleindirect | 152,691 | $94.81 | $14M | 5M | May 21, 2026 |
| May 20, 2026 | Robbins Larry | Director | open-market saleindirect | 66,881 | $95.67 | $6M | 5M | May 21, 2026 |
| May 20, 2026 | Robbins Larry | Director | open-market saleindirect | 800 | $96.28 | $77K | 5M | May 21, 2026 |
| May 19, 2026 | Robbins Larry | Director | open-market saleindirect | 2M | $94.45 | $187M | 6M | May 21, 2026 |
| May 19, 2026 | Robbins Larry | Director | open-market saleindirect | 151 | $95.18 | $14K | 6M | May 21, 2026 |
| May 14, 2026 | Aguirre Fernando | Director | award | 1,563 | $97.15 | $152K | 42,513 | May 15, 2026 |
| May 14, 2026 | Balser Jeffrey R. | Director | award | 2,058 | $97.15 | $200K | 15,717 | May 15, 2026 |
| May 14, 2026 | Kirby J Scott | Director | award | 1,447 | $97.15 | $141K | 14,434 | May 15, 2026 |
| May 14, 2026 | Norwalk Leslie V | Director | award | 1,447 | $97.15 | $141K | 7,376 | May 15, 2026 |
| May 14, 2026 | Sansone Guy P | Director | award | 1,447 | $97.15 | $141K | 15,106 | May 15, 2026 |
| May 14, 2026 | Brown C David II | Director | award | 1,544 | $97.15 | $150K | 129,316 | May 15, 2026 |
| May 8, 2026 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | open-market sale | 69,551 | $89.58 | $6M | 10,133 | May 11, 2026 |
| Apr 1, 2026 | Shah Prem S | EVP and Group President | tax withholding | 1,484 | $72.49 | $108K | 64,356 | Apr 2, 2026 |
| Apr 1, 2026 | Nelson Steven H | EVP and President, Aetna | tax withholding | 2,432 | $72.49 | $176K | 2,900 | Apr 2, 2026 |
| Apr 1, 2026 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | tax withholding | 3,634 | $72.49 | $263K | 79,684 | Apr 2, 2026 |
| Apr 1, 2026 | Khichi Samrat S. | EVP, CPO and General Counsel | tax withholding | 3,541 | $72.49 | $257K | 33,421 | Apr 2, 2026 |
| Apr 1, 2026 | Joyner J. David | President, CEO and Chair, Director | tax withholding | 8,029 | $72.49 | $582K | 70,349 | Apr 2, 2026 |
| Apr 1, 2026 | Clark James David | SVP, Cont & Chief Acct Officer | tax withholding | 3,262 | $72.49 | $236K | 15,457 | Apr 2, 2026 |
| Apr 1, 2026 | Capozzi Heidi B | EVP and Chief People Officer | tax withholding | 1,334 | $72.49 | $97K | 13,023 | Apr 2, 2026 |
| Mar 31, 2026 | Shah Prem S | EVP and Group President | award | 25,062 | $71.82 | $2M | 62,852 | Apr 2, 2026 |
| Mar 31, 2026 | Newman Brian | EVP, Chief Financial Officer | award | 19,493 | $71.82 | $1M | 41,354 | Apr 2, 2026 |
| Mar 31, 2026 | Nelson Steven H | EVP and President, Aetna | award | 22,277 | $71.82 | $2M | 43,606 | Apr 2, 2026 |
| Mar 31, 2026 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | award | 22,277 | $71.82 | $2M | 88,543 | Apr 2, 2026 |
| Mar 31, 2026 | Khichi Samrat S. | EVP, CPO and General Counsel | award | 12,531 | $71.82 | $900K | 38,139 | Apr 2, 2026 |
| Mar 31, 2026 | Joyner J. David | President, CEO and Chair, Director | award | 86,326 | $71.82 | $6M | 160,860 | Apr 2, 2026 |
| Mar 31, 2026 | Compton-Phillips Amy | EVP, Chief Medical Officer | award | 5,569 | $71.82 | $400K | 58,660 | Apr 2, 2026 |
| Mar 31, 2026 | Clark James David | SVP, Cont & Chief Acct Officer | award | 11,138 | $71.82 | $800K | 35,539 | Apr 2, 2026 |
| Mar 31, 2026 | Capozzi Heidi B | EVP and Chief People Officer | award | 10,025 | $71.82 | $720K | 84,450 | Apr 2, 2026 |
| Mar 19, 2026 | Gallina John E | Director | award | 582 | $71.86 | $42K | 582 | Mar 20, 2026 |
| Feb 28, 2026 | Khichi Samrat S. | EVP, CPO and General Counsel | tax withholding | 7,886 | $79.60 | $628K | 29,775 | Mar 2, 2026 |
| Feb 28, 2026 | Joyner J. David | President and CEO, Director | tax withholding | 1,944 | $79.90 | $155K | 49,996 | Mar 2, 2026 |
| Jan 1, 2026 | Shah Prem S | EVP and Group President | tax withholding | 247 | $80.13 | $20K | 61,509 | Jan 5, 2026 |
| Dec 1, 2025 | Clark James David | SVP, Cont & Chief Acct Officer | tax withholding | 220 | $79.10 | $17K | 24,401 | Dec 2, 2025 |
| Nov 30, 2025 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | tax withholding | 6,575 | $80.36 | $528K | 74,085 | Dec 2, 2025 |
| Nov 30, 2025 | Farah Roger N | Director | tax withholding | 9,748 | $80.36 | $783K | 19,438 | Dec 2, 2025 |
| Nov 30, 2025 | Capozzi Heidi B | EVP and Chief People Officer | tax withholding | 9,470 | $80.36 | $761K | 11,415 | Dec 2, 2025 |
| Nov 20, 2025 | Shulman Douglas H. | Director | award | 1,652 | $76.04 | $126K | 5,929 | Nov 21, 2025 |
| Nov 20, 2025 | Sansone Guy P | Director | award | 1,652 | $76.04 | $126K | 13,659 | Nov 21, 2025 |
| Nov 20, 2025 | Norwalk Leslie V | Director | award | 1,652 | $76.04 | $126K | 5,929 | Nov 21, 2025 |
| Nov 20, 2025 | Kirby J Scott | Director | award | 1,652 | $76.04 | $126K | 12,987 | Nov 21, 2025 |
| Nov 20, 2025 | Finucane Anne A. | Director | award | 591 | $76.04 | $45K | 591 | Nov 21, 2025 |
| Nov 20, 2025 | Brown C David II | Director | award | 1,775 | $76.04 | $135K | 127,772 | Nov 21, 2025 |
| Nov 20, 2025 | Balser Jeffrey R. | Director | award | 1,775 | $76.04 | $135K | 13,659 | Nov 21, 2025 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Robbins Larry | Director | May 21, 2026 | open-market sale | — | — | $317M (7) | 0 of 7 |
| Mandadi Tilak | EVP, Chief Exp & Tech Officer | May 8, 2026 | open-market sale | 10,133 | — | $6M (1) | 0 of 1 |
| Clark James David | SVP, Cont & Chief Acct Officer | Jun 26, 2026 | tax withholding | 27,606 | — | — | — |
| Shah Prem S | EVP and Group President | Apr 1, 2026 | tax withholding | 64,356 | — | — | — |
| Aguirre Fernando | Director | May 21, 2026 | disposition to issuer | 10,513 | — | — | — |
| Khichi Samrat S. | EVP, CPO and General Counsel | Apr 1, 2026 | tax withholding | 33,421 | — | — | — |
| Joyner J. David | President, CEO and Chair, Director | Apr 1, 2026 | tax withholding | 70,349 | — | — | — |
| Sansone Guy P | Director | May 14, 2026 | award | 15,106 | — | — | — |
| Capozzi Heidi B | EVP and Chief People Officer | Apr 1, 2026 | tax withholding | 13,023 | — | — | — |
| Compton-Phillips Amy | EVP, Chief Medical Officer | May 31, 2026 | tax withholding | 9,557 | — | — | — |
| Balser Jeffrey R. | Director | May 14, 2026 | award | 15,717 | — | — | — |
| Kirby J Scott | Director | May 14, 2026 | award | 14,434 | — | — | — |
| Norwalk Leslie V | Director | May 14, 2026 | award | 7,376 | — | — | — |
| Brown C David II | Director | May 14, 2026 | award | 129,316 | — | — | — |
| Nelson Steven H | EVP and President, Aetna | Apr 1, 2026 | tax withholding | 2,900 | — | — | — |
| Finucane Anne A. | Director | Nov 20, 2025 | award | 591 | — | — | — |
| Newman Brian | EVP, Chief Financial Officer | May 31, 2026 | tax withholding | 3,008 | — | — | — |
| Shulman Douglas H. | Director | Nov 20, 2025 | award | 5,929 | — | — | — |
| Mahoney Michael F | Director | May 15, 2025 | award | 6,345 | — | — | — |
| Cowhey Thomas F. | EVP and CFO | Apr 1, 2025 | tax withholding | 50,188 | — | — | — |
| Farah Roger N | Director | Nov 30, 2025 | tax withholding | 19,438 | — | — | — |
| Gallina John E | Director | Mar 19, 2026 | award | 582 | — | — | — |
| Millon Jean Pierre | Director | Nov 21, 2024 | award | 4,514 | — | — | — |
| Deparle Nancy Ann | Director | Nov 21, 2024 | award | 34,169 | — | — | — |
Questions
Are CVS Health insiders buying or selling?
Over the twelve months to November 1, 2026, 2 insiders at CVS Health sold $324M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $324M. Only open-market purchases and sales are counted.
Who sold the most CVS Health stock in the last year?
Robbins Larry (Director) sold $317M in 7 open-market sales over the twelve months to November 1, 2026.
Do CVS Health executives sell under 10b5-1 plans?
0 of the 8 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on CVS Health
- CVS Health financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.